Crossmark

Adjuvant chemoradiotherapy with procarbazine, lomustine, and vincristine (PCV) or temozolomide for 1p/19q Co-deleted anaplastic oligodendroglioma: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-025-15085-w

Published Online: 2025-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Santos, Monica D’Alma Costa https://orcid.org/0000-0001-5402-8226
Rodrigues, Natasha Maranhão Vieira

Gibram, Franceliny

Gouhie, Felipe Araujo

Campos, Ana Carolina Pinheiro

de Assis, Danielle Varin

Formentin, Cleiton

Feher, Olavo

de Souza e Silva, Alice Roxo Nobre

Hanna, Samir Abdallah

Chung, Caroline

Barbosa, Caroline Chaul

Moraes, Fabio Ynoe

Maldaun, Marcos Vinicius Calfat
License Information

Text and Data Mining valid from 2025-11-18

Version of Record valid from 2025-11-18
More Information

Article History

Received: 26 August 2025

Accepted: 22 September 2025

First Online: 18 November 2025

Declarations

:

: No applicable

: Not applicable

: The authors declare no competing interests.

Document is current

Any future updates will be listed below